Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...
When I first saw red paper chains strung up in my friend’s Brooklyn apartment last year, I thought: Cute! What a fun throwback to Christmases of yore, and a way to make the place ten times cozier as ...
Plume, a real world asset (RWA)-focused blockchain project, has debuted its Nest yield vaults directly on Solana, giving the network’s users native access to institutional-grade real-world assets for ...
After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...
MARSHALLTOWN, Iowa--(BUSINESS WIRE)--The Integration Group (TIG), a portfolio company of Maxwell Street Capital Partners (Maxwell Street), has acquired Matrix Management (Matrix), a Chicago-based ...
After 12 years leading Utah-based techbio company Recursion, CEO Chris Gibson is stepping down. Recursion’s R&D head and Chief Commercial Officer Najat Khan will become CEO effective Jan. 1. Gibson co ...
You can stop looking for glitches in the Matrix—it’s finally been proven that our universe is not merely a simulation running on some powerful alien civilization’s supercomputer. An international team ...
Laurence Fishburne on if He Would Return as Morpheus in ‘Matrix 5’: ‘I Don’t Know if it Makes Sense’
With last year’s news about “The Martian” screenwriter Drew Goddard taking the helm from Lana and Lily Wachowski for a new “Matrix” film, Laurence Fishburne expressed his hesitancy in reprising his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results